We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

First and Only Technology Uses Smartphone to Detect Heart Disease in One Minute at POC

By HospiMedica International staff writers
Posted on 25 Jan 2024
Print article
Image: A patented technology utilizes motion sensors to detect signs of heart disease (Photo courtesy of 123RF)
Image: A patented technology utilizes motion sensors to detect signs of heart disease (Photo courtesy of 123RF)

Atrial fibrillation, the most common cardiac arrhythmia, is symptomless in about 40% of patients. Even without symptoms, untreated atrial fibrillation can significantly increase the risk of stroke, heart failure, and death. Traditional detection methods, like ECG recordings in medical facilities, often miss atrial fibrillation due to its intermittent nature. This leads to a majority of cases remaining undiagnosed until severe complications, such as strokes, occur. Now, a groundbreaking technology can detect several major heart diseases with high accuracy using just a single clinical modality, without the need for specialized medical equipment.

CardioSignal’s (Turku, Finland) technology utilizes motion data from smartphone gyroscopes and accelerometers to monitor specific rotational movements of the heart. This innovative approach enables the precise detection of abnormal heart functions. The process involves placing a smartphone on the patient’s chest for one minute to gather data. A clinically validated algorithm then analyzes the motion data in a secure cloud service, delivering immediate results. The CardioSignal technology offers a non-invasive, accurate one-minute measurement for detecting atrial fibrillation signs. When atrial fibrillation indicators are found in two consecutive measurements, patients can be promptly referred for an ECG.

This method is patient-friendly, requiring no skin contact and offering comfort during the measurement. Early detection of atrial fibrillation in various healthcare settings, including clinics, pharmacies, and hospitals, can lead to timely medical intervention. Currently, CardioSignal's technology can generate digital biomarkers for atrial fibrillation and heart failure, validated in clinical studies, with further research underway to expand its capabilities to include detection of aortic stenosis, coronary artery disease, and pulmonary artery hypertension.

“Currently, primary care has very limited tools to detect heart diseases, like heart failure patients who are often already experiencing symptoms,” said cardiologist Dr. Juuso Blomster, founder and CEO of CardioSignal. “We can support the shift in cardiovascular care from treating complications to earlier detection and prevention.”

Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgical Needle
PORT-JECT

Print article

Channels

Surgical Techniques

view channel
Image: Electronic prompt for surgeons may reduce breast cancer overtreatment (Photo courtesy of 123RF)

EHR–Based Nudge Intervention for Surgeons to Reduce Breast Cancer Overtreatment

Sentinel lymph node biopsy (SLNB) is a critical surgical technique used to assess if breast cancer has spread to the underarm lymph nodes, although it's not necessary for all patients. Undergoing SLNB... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.